Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2007
03/21/2007CN1931897A Polyglycol modifier for benzoic acid/nitrobenzoic acid and its synthesis process
03/21/2007CN1931372A Brain targeting gene transfer and release system and its prepn process
03/21/2007CN1931370A Glycopeptide conjugate microsphere or microcapsule and its prepn process
03/21/2007CN1931369A Medicine composition containing cyclodextrin/polyene taxol and its prepn process
03/21/2007CN1931368A Medicine composition containing cyclodextrin included taxol and its prepn process
03/21/2007CN1931367A Application of alginate in preparing medicine smell masking prepn
03/21/2007CN1931365A Hcv e1e2 vaccine compositions
03/21/2007CN1931349A Antiviral eye drop containing zedoary oil
03/21/2007CN1931348A Hyperlipemia treating Chinese medicine prepn
03/21/2007CN1931337A Bock greenbrier rhizome micro pill and its prepn process
03/21/2007CN1931306A Chinese medicine soft capsule for treating urinary system diseases and its prepn process
03/21/2007CN1931266A Medicine composition for treating leukopenia and its prepn process
03/21/2007CN1931253A Leucoderma treating Chinese medicine
03/21/2007CN1931250A Fule micro pill and its prepn process
03/21/2007CN1931246A Medicine for treating burns and scalds and its prepn process
03/21/2007CN1931235A Medicine composition for treating cardiac and cerebral vascular diseases and its prepn process
03/21/2007CN1931232A Oil-in-water nanometer perilla seed oil emulsion oral liquid and its prepn process
03/21/2007CN1931207A Gymnema sylvestre total saponin inclusion compound and its prepn process
03/21/2007CN1931175A Medicine composition for preventing and treating farm animal's respiratory tract and digestive tract diseases
03/21/2007CN1931167A Double layer osmotic pump controlled release felodipine medicine composition
03/21/2007CN1931166A Hypertension treating medicine
03/21/2007CN1931165A Nanometer antifungal econazole nitrate emulsion medicine and its prepn process
03/21/2007CN1931164A Nanometer miconazole nitrate emulsion medicine and its prepn process
03/21/2007CN1931163A Nanometer clotrimazole emulsion medicine and its prepn process
03/21/2007CN1931158A Compound emulsion of docetaxel and volatil Chinese medicine oil for intravenous injection and its prepn process
03/21/2007CN1931155A Antibiotic medicine for treating bacterial infection of farm animal and aquatic animal
03/21/2007CN1931143A Orally taken control released trimetazidine medicine composition
03/21/2007CN1931137A Masked berberine hydrochloride micro pill and its prepn
03/21/2007CN1931135A Prepn process of superfine medicine powder with improved water solubility and its orally taken prepn
03/21/2007CN1931133A Total arasaponin precursor liposome and its prepn process
03/21/2007CN1931132A Externally applied filming medicine spray
03/21/2007CN1931131A Oil-in-water type nanometer peonol emulsion oral liquid and its prepn process
03/21/2007CN1931130A Nanometer emulsion oral liquid of andrographolide and its prepn process
03/21/2007CN1931129A Process of preparing biodegradable magnetic medicine carrying polymer microsphere
03/21/2007CN1931120A Non-crystalline perfume or flavour delivery system
03/21/2007CN1305932C Carbohydrate-modified polymers, compositions and uses related thereto
03/21/2007CN1305931C Agent for the prevention and treatment of sexually transmitted diseases-1
03/21/2007CN1305916C Temperature sensitive linear polymer containing siloxane side chain and its water gel and preparing method
03/21/2007CN1305529C Use of IL-18 inhibitors for treating or preventing CNS injuries
03/21/2007CN1305528C Immunoadjuvant
03/21/2007CN1305527C Vaccine for treating hepatitis B, and its preparation. method
03/21/2007CN1305470C Process for preparing a finely self-emulsifiable pharmaceutical composition
03/21/2007CN1305467C Zinc containing compositions for anti-viral use
03/21/2007CN1305462C Diffusional implantable delivery system
03/20/2007US7193031 Complexing with active material such as drug
03/20/2007US7192984 Compositions of polyacids and polyethers and methods for their use as dermal fillers
03/20/2007US7192941 Estradiol metabolites for the treatment of pulmonary hypertension
03/20/2007US7192938 Orally administered risedronic acid or salt for osteoporosis or bone disorder treatment
03/20/2007US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
03/20/2007US7192928 T cell antigen receptor peptides
03/20/2007US7192744 Composition for use in the targeted transfection of cells
03/20/2007US7192736 Nucleic acid molecules encoding cytotoxic conjugates that contain a chemokine receptor targeting agent
03/20/2007US7192596 Recombinant toxin fragments
03/20/2007US7192582 Human monoclonal antibodies to FC alpha receptor (CD89)
03/20/2007CA2438768C Improved flexible collodion compositions
03/20/2007CA2411787C Stable gabapentin having ph within a controlled range
03/20/2007CA2364845C Extending the duration of drug release within the stomach during the fed mode
03/20/2007CA2360655C Pharmaceutical compositions
03/20/2007CA2337047C Method of obscuring immune recognition
03/20/2007CA2315115C Compositions of microspheres for wound healing
03/20/2007CA2223080C Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2,5-anhydro-d-mannose terminal structure and conjugate vaccine thereof
03/20/2007CA2211926C Fructan - and/or polydextrose - containing dairy powders, process for preparing same and their use
03/20/2007CA2142280C Metal-mediated cross-coupling with ring-metalated porphyrins
03/15/2007WO2007030718A2 Omega-3 fatty acids encapsulated in zein coatings and food products incorporating the same
03/15/2007WO2007030623A2 Bi-modal hyaluronate solution
03/15/2007WO2007030023A1 A medical composition for treating wounds
03/15/2007WO2007030012A2 Extracellular matrix imaging
03/15/2007WO2007029781A1 Adhesive preparation containing bisoprolol
03/15/2007WO2007029660A1 Microparticle of hardly-soluble substance having enteric base material adsorbed on the surface of the substance
03/15/2007WO2007029484A1 Lactoferrin complex and method of producing the same
03/15/2007WO2007029376A1 Orally rapidly disintegrating tablet
03/15/2007WO2007029361A1 Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same
03/15/2007WO2007029345A1 Tyrosinase activity inhibitor
03/15/2007WO2007029198A2 Sanitary napkins with hydrophobic lotions
03/15/2007WO2007029003A2 Method of preparing a hydrogel
03/15/2007WO2007028599A2 A fluorescent photoprobe for the imaging of endothelin receptors
03/15/2007WO2007028347A2 Method for the preparation of polymeric conjugates of doxorubicin with ph- controlled release of the drug
03/15/2007WO2007028341A1 Nano anticancer micelles of vinca alkaloids entrapped in polyethylene glycolylated phospholipids
03/15/2007WO2007028258A2 Interpenetrating networks, and related methods and compositions
03/15/2007WO2007028247A1 Fast-disintegrating epinephrine tablets for buccal or sublingual administration
03/15/2007WO2007011575A3 Method and composition for bone growth
03/15/2007WO2006131401A3 Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent
03/15/2007WO2006127284A3 Method of purifying apo-2 ligand/trail using crystallisation in the cold
03/15/2007WO2006121422A3 Antibodies against clostridium difficile toxins and uses thereof
03/15/2007WO2006119897A3 Fusion protein of antibody l19 against fibronectin ed-b and interleukin 12
03/15/2007WO2006108373A8 COMPLEXES CONSISTING OF VITAMIN D-COMPOUNDS OR ANALOGUES THEREOF HAVING A 5Z,7E,10(19)-TRIENE SYSTEM AND METHYLATED DERIVATIVES OF ß-CYCLODEXTRIN
03/15/2007WO2006061853A3 Novel erythropoietic compounds and a process for producing erythropoietic compounds
03/15/2007WO2006059110A3 Plad domain peptides with increased serum half life due to conjugation to domain antibodies
03/15/2007WO2006027711A3 Prodrugs and codrugs containing bio- cleavable disulfide linkers
03/15/2007WO2006005621A3 Method for producing albumen/corticoid conjugates
03/15/2007WO2005094898A3 Chemically modified protein compositions and methods
03/15/2007WO2005079861A3 Polymeric water soluble prodrugs
03/15/2007WO2004091499A3 Intracellular formation of peptide conjugates
03/15/2007WO2004024073A3 Use of statins in the prevention and treatment of radiation injury and other disorders associated with reduced endothelial thrombomodulin
03/15/2007WO2003068169A3 Stabilized synthetic immunogen delivery system
03/15/2007US20070060636 High enantiomeric purity dexanabinol for pharmaceutical compositions
03/15/2007US20070060635 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
03/15/2007US20070060627 Organic compounds
03/15/2007US20070060621 Methods and compositions for the administration of prodrugs of proton pump inhibitors
03/15/2007US20070060544 4-Nitro-2-[(4'-methoxy)-phenoxy]-methanesulfonanilide derivatives and their pharmaceutical use
1 ... 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 ... 1712